<DOC>
	<DOCNO>NCT01678482</DOCNO>
	<brief_summary>This clinical research study determine ability Clear device treat mild moderate inflammatory acne , determine average person able use device properly accord label describe operator manual . The study involve treatment twice week 4 week total 8 treatment session , subject treat Clear device , 2 follow-up visit evaluate result . The clinical result assess investigator improvement acne condition . Treatment perform face subject enrol meet inclusion criterion .</brief_summary>
	<brief_title>Clinical Usability Study Determine Safety Efficacy Clear Device Acne Treatment</brief_title>
	<detailed_description>The subject recruit eligible participate study accord device labeling present doctor 's office print ad . Subjects give information Clear device accord labeling . After read information labeling , subject ' decision understand device label information want participate study . The investigator review inclusion / exclusion criterion subject ensure eligibility .</detailed_description>
	<criteria>1 . Presence mild moderate acne . 2 . Skin Type I VI ( Fitzpatrick ) . 3 . Males females 2165 year old . 4 . Willingness follow treatment schedule , posttreatment care photograph take . 1 . Pacemaker internal defibrillator . 2 . Permanent implant treat area , metal plate screw silicon , unless deep enough bone . 3 . Skin area inject Botox/ Hyaluronic acid /collagen/fat injection augmentation method biomaterial last 6 month . 4 . Current history skin cancer , type cancer , premalignant mole . 5 . Current severe medical condition , heart lung disorder . 6 . Pregnant breastfeeding . 7 . Impaired immune system due immunosuppressive disease AIDS HIV , use immunosuppressive medication . 8 . History disease stimulate heat , recurrent Herpes Simplex ( cold sore ) treatment area , unless treat follow preventive regime . 9 . Poorly control endocrine disorder , diabetes thyroid disorder . 10 . Any active skin condition treatment area , sore , psoriasis , eczema , rash rosacea . 11 . History skin disorder , keloid ( excessive scarring ) , abnormal wound healing , well dry fragile skin . 12 . History bleed disorder , use anticoagulant last 10 day . 13 . Any facial surgery perform within 12 month prior treatment . 14 . Facial dermabrasion , facial resurfacing , deep chemical peeling within last 3 month . 15 . Received treatment light , laser , radiofrequency ( RF ) , device treat area within 6 month . 16 . Used isotretinoin ( Accutane® ) within 6 month prior treatment . 17 . Using nonsteroidal antiinflammatory drug ( NSAIDS , e.g. , ibuprofencontaining agent ) 1 week treatment session . 18 . Subjects currently recently treat AlphaHydroxi Acids ( AHAs ) , BetaHydroxi Acids ( BHAs ) , RetinA® , topical retinoids azelaic acid . 19 . Subjects steroid regimen within past 3 month .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Acne , LED , blue light</keyword>
</DOC>